Search

everythinglearnresearchcommunity

for

Search:↓

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Caffeine-based liquid 0.2% is as effective as minoxidil 5% for treating male hair loss.

Both genetic and lifestyle factors significantly affect female hair loss.

CD34 marks potential stem cells in dog hair follicles.

Mesenchymal stromal cells may help treat severe COVID-19, but more research is needed to confirm their effectiveness.

Using stem cells from fat tissue can significantly improve wound healing in dogs.

SVF-PRP therapy effectively reverses hair loss effects.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Recent advances in hair loss treatments show significant progress.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

Increasing Wnt5a in mice skin delays hair growth but doesn't stop it.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

PRP injections improve hair density and thickness in women with hair loss.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

The research suggests that the ZP4 gene is linked to egg development in women with PCOS but requires more study to understand its role in infertility.

Certain proteins and their receptors are more active during the growth phase of human hair and could be targeted to treat hair disorders.

The document concludes that managing side effects of MS therapies is crucial for treatment success and patient adherence.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

The osteopontin gene is active in a specific part of rat hair follicles during a certain hair growth phase and might affect hair cycle and diseases.

Erythropoietin helps hair grow and could be a potential treatment for hair loss.

Minoxidil effectively treats hair loss, especially androgenetic alopecia, but needs more research for better understanding.

3D cell-derived matrices improve tissue regeneration and disease modeling.

The PS-b-PAA copolymer nanomicelles are effective for delivering a cancer treatment drug in photodynamic therapy.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.

Scientists made all eight versions of a compound called cyoctol, but found it's not an anti-androgen and it fully breaks down in the skin.

Atorvastatin reversed memory problems caused by cancer drug trastuzumab and improved its cancer-fighting abilities without causing hair loss.

Low-level laser treatment helps mice grow hair by increasing certain protein levels linked to hair growth.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.